Framingham Heart Study, Boston University School of Medicine
The Framingham Heart Study is a project of Boston University and the National Heart Lung and Blood Institute.
The Framingham Heart Study is a project of Boston University and the National Heart Lung and Blood Institute.
The Framingham Heart Study is a renowned project of Boston University School of Medicine and the National Heart Lung and Blood Institute, founded in 1948. It has been instrumental in researching heart disease and several chronic diseases including stroke, cancer, osteoporosis, diabetes, and Alzheimer's disease. With over 3,800 articles published in prestigious academic journals, including the New England Journal of Medicine, the Journal of the American Medical Association, Nature Genetics, Circulation, and the Lancet, FHS has gained global recognition. The study is now venturing into new avenues, such as genomics, transcriptomics, and proteomics, incorporating state-of-the-art technology. The last investment of $38.00M in the form of a grant was received on 16 April 2019 from the National Heart, Lung and Blood Institute.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $38.00M | 1 |
|
16 Apr 2019 |
No recent news or press coverage available for Framingham Heart Study, Boston University School of Medicine.
We care about your data, and we'd love to use cookies make your experience better.
